As Cancer Registrars we all hear physicians and cancer conference participants talk about the risk of a DCIS recurrence. In this short video Dr. Rick Baehner, Senior Director of Pathology at Genomic Health, talks about what DCIS breast cancer patients can expect in terms of percentages.
Here’s an interesting oncology service called @TumorBoard. “@TumorBoard is a web based platform that provides real time support for both engaged physicians and their cancer patients. Traditionally excluded from the decision-making process characteristic of most hospital based tumor boards, the inclusion of the patient promotes a patient centered or integrated care approach characteristic of the […]